Assessment of the French colistin action plan - Anses - Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail Access content directly
Conference Poster Year : 2022

Assessment of the French colistin action plan


The discovery of the plasmid resistance gene to colistin mcr-1 in 2015, profoundly changed the way this widely used molecule in veterinary medicine in France was considered. National management measures have been set up to reduce its use in animals, in line with European recom-mendations. Two objectives were defined: that of the AMEG in 2016, to reach a consumption of less than 5mg/kg in 3 to 4 years and that defined by the Ecoantibio2 national plan of a 50% reduction in the cattle, pig and poultry sectors in 5 years compared to the 2014-2015 use. In order to assess the effectiveness of these measures, French sales, usages and resistance surveillance data were analysed.
No file

Dates and versions

anses-04084027 , version 1 (27-04-2023)


  • HAL Id : anses-04084027 , version 1


Elsa Coz, Eric Jouy, Géraldine Cazeau, Nathalie Jarrige, Agnes Perrin-Guyomard, et al.. Assessment of the French colistin action plan. Third International Conference AACTING: Quantification, Benchmarking and Stewardship of Veterinary Antimicrobial Usage, May 2022, Hannover, Germany, Germany. , 2022. ⟨anses-04084027⟩
19 View
0 Download


Gmail Facebook X LinkedIn More